Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/13/2012 | WO2012171024A2 Enzyme directed assembly of particle theranostics |
12/13/2012 | WO2012171020A1 Protein-polymer-drug conjugates |
12/13/2012 | WO2012170796A1 Gel compositions |
12/13/2012 | WO2012170061A1 Formulations of (r)-1-(2,2-diflurobenzo[d][1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methyl propan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
12/13/2012 | WO2012169972A1 Core-shell microspheres |
12/13/2012 | WO2012169735A2 Complex comprising water-soluble fragments of fcεri and composition comprising same for treating allergic diseases mediated by ige |
12/13/2012 | WO2012169677A1 Composition for controlling gastric retention and release |
12/13/2012 | WO2012169661A1 Monatin polyvalent metal salt crystal |
12/13/2012 | WO2012169614A1 Method for producing orodispersible tablets |
12/13/2012 | WO2012169417A1 Film-like anesthetic drug |
12/13/2012 | WO2012168891A1 Process for the preparation of a metal complex in an oily organic matrix |
12/13/2012 | WO2012168432A1 Polypeptides |
12/13/2012 | WO2012168431A2 Polypeptides |
12/13/2012 | WO2012168430A2 Polypeptides |
12/13/2012 | WO2012167882A1 Composition for oral delivery of biologically-active substances |
12/13/2012 | WO2012167870A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier |
12/13/2012 | WO2012167350A1 Method for the synthesis of porphyrin-phospholipid conjugates |
12/13/2012 | WO2012167309A1 Macromolecules |
12/13/2012 | WO2012143608A3 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract |
12/13/2012 | WO2012143499A3 Novel binder-drug conjugates (adcs) and their use |
12/13/2012 | WO2012143495A3 Novel binder-drug conjugates (adcs) and their use |
12/13/2012 | WO2012136792A3 Cck compositions |
12/13/2012 | WO2012131412A3 Pharmaceutical composition containing no, process for the preparation and use thereof |
12/13/2012 | WO2012109473A3 Detection of endotoxins |
12/13/2012 | WO2012094653A3 Compositions and methods for macromolecular drug delivery |
12/13/2012 | WO2012022478A3 Filler composition comprising beta-glucans |
12/13/2012 | US20120316520 Transdermal therapeutic system for administering lipophilic and/or sparingly skin-permeable active substances |
12/13/2012 | US20120316250 Hard capsule and method for producing same |
12/13/2012 | US20120316134 Anaesthetic composition |
12/13/2012 | US20120316133 Aqueous iron carbohydrate complexes, their production and medicaments containing them |
12/13/2012 | US20120316108 Phospholipid depot |
12/13/2012 | US20120315329 Siloxane surface-modified hydrogel and hydrogel microparticle compositions |
12/13/2012 | US20120315315 Foam Formulations Containing at Least One Triterpenoid |
12/13/2012 | US20120315306 Pharmaceutical composition and preparation for oral administration |
12/13/2012 | US20120315301 Preparation of vesicle-type carbon nanotubes |
12/13/2012 | US20120315299 Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
12/13/2012 | US20120315293 Antigen Delivery Vectors and Constructs |
12/13/2012 | US20120315265 Hydrogel-forming polymer, and preparation process and uses thereof |
12/13/2012 | US20120315238 Preparation of Polyacrylates by Emulsion Polymerization |
12/13/2012 | US20120315237 Associative Thickeners Based on Methacrylate |
12/13/2012 | US20120315229 Clarifying agents for organomodified silicones |
12/13/2012 | US20120315225 Dimensionally stable nonwoven fibrous webs and methods of making and using the same |
12/13/2012 | CA2838884A1 Polypeptides |
12/13/2012 | CA2838833A1 Pro-coagulant compounds and methods of use thereof |
12/13/2012 | CA2838573A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier |
12/13/2012 | CA2837979A1 Macromolecules |
12/13/2012 | CA2837901A1 Method for the synthesis of porphyrin-phospholipid conjugates |
12/13/2012 | CA2837840A1 Protein-polymer-drug conjugates |
12/13/2012 | CA2835293A1 Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration |
12/12/2012 | EP2532684A2 Cellulose interpolymers and method of oxidation |
12/12/2012 | EP2532683A2 Cellulose interpolymers and method of oxidation |
12/12/2012 | EP2532676A1 Protease-regulated antibody |
12/12/2012 | EP2532369A2 Factor VIIa-(poly)sialic acid conjugate having prolonged in vivo half-life |
12/12/2012 | EP2532368A1 "Composition for oral delivery of biologically-active substances" |
12/12/2012 | EP2532352A1 Stabilized Sulforaphane |
12/12/2012 | EP2531548A1 Method for solubilizing hydrophobic active ingredients in an aqueous solution |
12/12/2012 | EP2531224A2 Compositions and methods relating to argininosuccinate synthetase |
12/12/2012 | EP2531222A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
12/12/2012 | EP2531221A1 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
12/12/2012 | EP2531220A2 Active scaffolds for on-demand drug and cell delivery |
12/12/2012 | EP2531219A1 Carrier composition |
12/12/2012 | EP2531218A1 Immunoglobulin preparation |
12/12/2012 | EP2531213A2 Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination |
12/12/2012 | EP2531209A2 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
12/12/2012 | EP2531188A1 Treatment of respiratory disorders |
12/12/2012 | EP2531173A2 Taxane-and taxoid-protein compositions |
12/12/2012 | EP2531167A1 Hair follicle targeting compositions |
12/12/2012 | EP2531047A1 Carrier comprising non-neutralised tocopheryl phosphate |
12/12/2012 | EP2531046A1 A method for altering the flavor of a food product |
12/12/2012 | EP2531026A1 Polysaccharide based antimicrobial formulations |
12/12/2012 | CN1956998B Method for the purification of albumin conjugates |
12/12/2012 | CN1899644B Methods and apparatus for improved administration of pharmaceutically active compounds |
12/12/2012 | CN102822198A CTLA4 proteins and their uses |
12/12/2012 | CN102821791A 透皮递送贴剂 Transdermal delivery patch |
12/12/2012 | CN102821756A Oil-in-water type nano-emulsion composition and method for preparing same |
12/12/2012 | CN102821755A Fast dissolving pharmaceutical composition |
12/12/2012 | CN102821754A Multilayer melt-extruded film |
12/12/2012 | CN102821753A Intracameral sustained release therapeutic agent implants |
12/12/2012 | CN102817105A Preparation method of core-shell structured synthetic polymer-natural polymer composite fiber |
12/12/2012 | CN102816724A Rhizobium radiobacter, extracellular polysaccharide thereof and application of extracellular polysaccharide |
12/12/2012 | CN102816347A Botanical hollow capsule, and preparation technology and preparation system thereof |
12/12/2012 | CN102816274A Silica/poly(methyl methacrylate-styrene) double-layered composite microsphere and its preparation method |
12/12/2012 | CN102816262A Preparation method of p-methylphenyl ethanol substituted 6-amino-beta-cyclodextrin derivative |
12/12/2012 | CN102816242A Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
12/12/2012 | CN102816241A Albumin fusion proteins |
12/12/2012 | CN102816215A Smallish polypeptide capable of inhibiting HIV and medicinal use thereof |
12/12/2012 | CN102816197A New pyrimidopyrimidine nucleoside analogue, its preparation method, supermolecular structure formed by the same and application thereof |
12/12/2012 | CN102816111A Oligomer-Protease Inhibitor Conjugates |
12/12/2012 | CN102815935A Ceramic particle group and method for production thereof and use thereof |
12/12/2012 | CN102814153A Preparation and application of composite structure microsphere with color change ability |
12/12/2012 | CN102813942A Lipid ultrasound microbubble mediated adeno-associated virus gene transfection preparation and preparation technology thereof |
12/12/2012 | CN102813938A Llex A-cyclodextrin polymer medicine composition for preventing and curing atherosclerosis and preparation method thereof |
12/12/2012 | CN102813937A Hydrophobic drug containing polyelectrolyte complex, its preparation method and application thereof |
12/12/2012 | CN102813936A Hollow capsule made of konjak |
12/12/2012 | CN102813935A Application of non-woven fabric in preparing drug for treating oral diseases and preparation |
12/12/2012 | CN102813934A Moistureproof film coating agent for traditional Chinese medicine tablets and preparation method thereof |
12/12/2012 | CN102813933A Chicken infectious bursal disease egg yolk antibody cryoprotectant |
12/12/2012 | CN102813932A Duck viral hepatitis egg yolk antibody cryoprotectant |
12/12/2012 | CN102813931A Chitosan nanoparticles and their preparation method and use |
12/12/2012 | CN102813930A Preparation method of magnetically targeted localization magnetic drug carrier |